- Contents:
- Phone Number /
- Social Networks /
- Address /
- Help Page
Overview
Through cutting-edge science and medicine, Biogen discovers, develops and delivers innovative therapies worldwide for people living with serious neurological and neurodegenerative diseases.
Founded in 1978, Biogen is a pioneer in biotechnology and today the Company has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved treatment for spinal muscular atrophy, and is at the forefront of neurology research for conditions including Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis. Biogen also manufactures and commercializes biosimilars of advanced biologics.
With approximately 7000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Zug, Switzerland and we have world-class manufacturing facilities in North Carolina and Denmark. We offer therapies globally through direct affiliate presence in 30 countries and a network of distribution partners in over 50 additional countries.
For more information, please visit www.biogen.com. Follow us on social media – Twitter, LinkedIn, Facebook, YouTube.
Industry | Biotechnology Research |
Headquarters | Cambridge, MA |
Company size | 5,001-10,000 employees |
Website | http://www.biogen.com |
Specialties |
Customer Service Number [Biogen]:
Customer Service number | +1 781 464 2000 |
Customer Service number
(Disease Education Line) |
+1 833 913 2098 |
Customer Service number | +1 800 456 2255 |
Customer Service number
(SMA360) |
+1 844 477 4672 |
Customer Service number
(Medical Information) |
+1 866 633 4636 |
[Media] contact number | +1 781 464 3260 |
[Investors] contact number | +1 781 464 2442 |
[Legal] contact number
(US and Canada through the Compliance Helpline) |
+1 866 418 2859 |
Support Email(s) [Biogen]:
[Business Customer Service] email |
|
[Customer Service] email
(Medical Information) |
|
[Media] contact email
(US Corporate Affairs/ Media Inquiries) |
|
[Media] contact email
(EU Corporate Affairs/ Media Inquiries) |
|
[Investors/ Franchising] contact email |
|
[Legal] contact email
(Privacy Inquiries) |
|
Social Networks [Biogen]: